Slow-acting, disease-modifying osteoarthritis agents (Q38556875)

4 September 2017

1 reference

title

Slow-acting, disease-modifying osteoarthritis agents (English)

1 reference

4 September 2017

1 reference

McNamara PS

1

1 reference

4 September 2017

Johnston SA

series ordinal

2

1 reference

4 September 2017

Todhunter RJ

series ordinal

3

1 reference

4 September 2017

publication date

1 July 1997

1 reference

Veterinary Clinics of North America: Small Animal Practice

4 September 2017

published in

1 reference

4 September 2017

volume

27

1 reference

4 September 2017

issue

4

1 reference

4 September 2017

page(s)

863-881

1 reference

Therapeutic treatment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Prophylactic treatment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

The interaction of pentosan polysulphate (SP54) with human neutrophil elastase and connective tissue matrix components

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Nomenclature of hyaluronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Relation Between Lipophilicity and Pharmacological Behavior of Minocycline, Doxycycline, Tetracycline, and Oxytetracycline in Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Doxycycline disrupts chondrocyte differentiation and inhibits cartilage matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Evaluation of polysulfated glycosaminoglycan for the treatment of hip dysplasia in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. II. Cartilage composition and proteoglycan metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. I. Gait analysis and radiological and morphological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Interactions of pentosan polysulfate with cartilage matrix proteins and synovial fibroblasts derived from patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Systemic administration of glycosaminoglycan polysulphate (arteparon) provides partial protection of articular cartilage from damage produced by meniscectomy in the canine

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Changes in the synovia after the intra-articular injection of sodium hyaluronate into normal horse joints and after arthrotomy and experimental cartilage damage

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Effects of hexosamine derivatives and uronic acid derivatives on glycosaminoglycane metabolism of fibroblast cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Release of plasminogen activator by pentosan polysulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Effect of hylan on cartilage and chondrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Catabolism of Hyaluronan in the Knee Joint of the Rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Serum kinetics of doxycycline polyphosphate in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

A new approach to the treatment of osteoarthritis: viscosupplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Systemic use of pentosan polysulphate in the treatment of osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

The effects of orally administered calcium pentosan polysulfate on inflammation and cartilage degradation produced in rabbit joints by intraarticular injection of a hyaluronate-polylysine complex

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Effects of exercise and polysulfated glycosaminoglycan on repair of articular cartilage defects in the equine carpus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Effects of exercise and polysulfated glycosaminoglycan on the development of osteoarthritis in equine carpal joints with osteochondral defects

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

The metabolic fate of intravenously injected peptide-bound chondroitin sulphate in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2897%2950084-2

7 January 2021

10.1016/S0195-5616(97)50084-2

Identifiers

DOI

1 reference

4 September 2017

1 reference